Clinical Trial

Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma

Study acronym: Tirbaso
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
his is a Phase 2, Single-Arm, Open-Label, Single Center, to Assess Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects with superficial basal cell carcinoma (sBCC) not arising on the face or scalp
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-10-27; most recent amendment 2026-06-18.
Status change: Not Yet Recruiting → Recruiting 2024-03-15
Trial Details
NCT Number NCT06112522
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Cell Carcinoma
Enrollment 50 participants
Start Date 2024-02-16
Primary Completion 2027-12-16 (estimated)
Study Completion 2027-12-16 (estimated)
Updated on ClinicalTrials.gov 2026-06-22